FDA’s Califf backs limited use of single-arm trials, but says regulatory pathways for some cancers should 'move into a new phase'
https://www.fiercebiotech.com/biotech/fdas-califf-says-many-cases-regulatory-pathways-cancer-should-move-new-phase
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.